跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
INREBIC fedratinib (as hydrochloride) 100 mg capsule bottle - TGA Drug Approval Details
Approvals
/
TGA
/
INREBIC fedratinib (as hydrochloride) 100 mg capsule bottle
Approved
STANDARD
INREBIC fedratinib (as hydrochloride) 100 mg capsule bottle
Bristol-Myers Squibb Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
eaa0a36b0d282601
Company
Bristol-Myers Squibb Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
eaa0a36b0d282601
Product Name
INREBIC fedratinib (as hydrochloride) 100 mg capsule bottle
Artg Id
433750
Artg Name
INREBIC fedratinib (as hydrochloride) 100 mg capsule bottle
Sponsor
Bristol-Myers Squibb Australia Pty Ltd
Company Detail Path
/organization/bristol-myers-squibb-australia-pty-ltd
Artg Date
2025-02-13
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
eaa0a36b0d282601
Type
Standard
Back to TGA Approvals
